Samsara Therapeutics

Samsara Therapeutics is a biotech company in Oxford, United Kingdom, founded in 2019. It has raised $3.2M across 1 round, most recently a $3.2M Seed in 2019 (est.).

Treating Neurodegeneration by Improving Autophagy.

Headquarters
Oxford
Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$3.2M
Last Round
$3.2M SeedJan 2019
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Samsara Therapeutics was founded in 2019 and operates from its corporate headquarters in Boston, Massachusetts, and an R&D hub in Oxford, UK. The company is pursuing therapeutics for neurodegenerative diseases through autophagy activation, running an in-house discovery platform for high-throughput, cell-based screening of small-molecule autophagy activators in disease-relevant, patient-derived iPSCs. In 2021, Apollo Health Ventures led its $25M Series A, and the company has also received endorsement and funding from patient advocacy organizations including the ALS Association, the Michael J Fox Foundation, and the CMT Research Foundation.

Summary

It lists 1–10 employees. It has raised $3.2M in total across 1 round, most recently a $3.2M Seed round in 2019 (est.). Investors include Apollo Health Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed Round2019 (est.)
$3.2M

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series ETotal funding$1.1BSep 2026
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Samsara Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/samsara-therapeutics"><img src="https://indexed.vc/api/badge/company/samsara-therapeutics" alt="Samsara Therapeutics on Indexed.vc" width="260" height="76" /></a>